FDA Inspection 1109239 - Gland Pharma Limited, Units I+II Pashamylaram Site - November 07, 2019

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gland Pharma Limited, Units I+II Pashamylaram Site

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on November 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date: November 7, 2019
Product Type: Drugs
Office: Center for Drug Evaluation and Research

Open in Dashboard

ID · b1e79e8a-4766-4a82-8ce3-2f50924d5757

Violation Codes4

21 CFR 211.160(b)21 CFR 211.19221 CFR 211.46(b)21 CFR 211.84(b)

Full citation text and observation details available on the Dashboard.